1052 related articles for article (PubMed ID: 29310114)
21. Dysbiosis in gastrointestinal disorders.
Chang C; Lin H
Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):3-15. PubMed ID: 27048892
[TBL] [Abstract][Full Text] [Related]
22. Connection between gut microbiome and the development of obesity.
Zhi C; Huang J; Wang J; Cao H; Bai Y; Guo J; Su Z
Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):1987-1998. PubMed ID: 31367997
[TBL] [Abstract][Full Text] [Related]
23. Obesity-Linked Gut Microbiome Dysbiosis Associated with Derangements in Gut Permeability and Intestinal Cellular Homeostasis Independent of Diet.
Nagpal R; Newman TM; Wang S; Jain S; Lovato JF; Yadav H
J Diabetes Res; 2018; 2018():3462092. PubMed ID: 30250849
[TBL] [Abstract][Full Text] [Related]
24. Intestinal microbiota are involved in the immunomodulatory activities of longan polysaccharide.
Zhang J; Yang G; Wen Y; Liu S; Li C; Yang R; Li W
Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28679026
[TBL] [Abstract][Full Text] [Related]
25. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction.
Drossman DA; Hasler WL
Gastroenterology; 2016 May; 150(6):1257-61. PubMed ID: 27147121
[No Abstract] [Full Text] [Related]
26. [Alteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?].
Genser L; Poitou C; Brot-Laroche É; Rousset M; Vaillant JC; Clément K; Thenet S; Leturque A
Med Sci (Paris); 2016 May; 32(5):461-9. PubMed ID: 27225918
[TBL] [Abstract][Full Text] [Related]
27. The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity.
Holota Y; Dovbynchuk T; Kaji I; Vareniuk I; Dzyubenko N; Chervinska T; Zakordonets L; Stetska V; Ostapchenko L; Serhiychuk T; Tolstanova G
PLoS One; 2019; 14(8):e0220642. PubMed ID: 31437166
[TBL] [Abstract][Full Text] [Related]
28. The Gut Ecosystem: A Critical Player in Stroke.
Delgado Jiménez R; Benakis C
Neuromolecular Med; 2021 Jun; 23(2):236-241. PubMed ID: 33206321
[TBL] [Abstract][Full Text] [Related]
29. The possible mechanisms of the human microbiome in allergic diseases.
Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
[TBL] [Abstract][Full Text] [Related]
30. SCFA: mechanisms and functional importance in the gut.
Martin-Gallausiaux C; Marinelli L; Blottière HM; Larraufie P; Lapaque N
Proc Nutr Soc; 2021 Feb; 80(1):37-49. PubMed ID: 32238208
[TBL] [Abstract][Full Text] [Related]
31. Bacillus clausii and gut homeostasis: state of the art and future perspectives.
Lopetuso LR; Scaldaferri F; Franceschi F; Gasbarrini A
Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):943-8. PubMed ID: 27291780
[TBL] [Abstract][Full Text] [Related]
32. The diet-microbiota-metabolite axis regulates the host physiology.
Yamada T; Takahashi D; Hase K
J Biochem; 2016 Jul; 160(1):1-10. PubMed ID: 26970281
[TBL] [Abstract][Full Text] [Related]
33. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
Shabbir U; Arshad MS; Sameen A; Oh DH
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
[TBL] [Abstract][Full Text] [Related]
34. Gut microbiome and type 2 diabetes: where we are and where to go?
Sharma S; Tripathi P
J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
[TBL] [Abstract][Full Text] [Related]
35. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
36. Metformin: old friend, new ways of action-implication of the gut microbiome?
Rodriguez J; Hiel S; Delzenne NM
Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):294-301. PubMed ID: 29634493
[TBL] [Abstract][Full Text] [Related]
37. The role of the gut microbiota in NAFLD.
Leung C; Rivera L; Furness JB; Angus PW
Nat Rev Gastroenterol Hepatol; 2016 Jul; 13(7):412-25. PubMed ID: 27273168
[TBL] [Abstract][Full Text] [Related]
38. Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier.
Usuda H; Okamoto T; Wada K
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299233
[TBL] [Abstract][Full Text] [Related]
39. Gut-Liver Physiomimetics Reveal Paradoxical Modulation of IBD-Related Inflammation by Short-Chain Fatty Acids.
Trapecar M; Communal C; Velazquez J; Maass CA; Huang YJ; Schneider K; Wright CW; Butty V; Eng G; Yilmaz O; Trumper D; Griffith LG
Cell Syst; 2020 Mar; 10(3):223-239.e9. PubMed ID: 32191873
[TBL] [Abstract][Full Text] [Related]
40. The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases.
Silva MJ; Carneiro MB; dos Anjos Pultz B; Pereira Silva D; Lopes ME; dos Santos LM
J Immunol Res; 2015; 2015():321241. PubMed ID: 25759839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
